Incidence of Adverse Drug Reactions in COVID‐19 Patients in China: An Active Monitoring Study by Hospital Pharmacovigilance System-Reference-Cited by-同舟云学术

Incidence of Adverse Drug Reactions in COVID‐19 Patients in China: An Active Monitoring Study by Hospital Pharmacovigilance System

Published:2020-05-26 Issue:4 Volume:108 Page:791-797
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Sun Ji¹,Deng Xuanyu¹,Chen Xiaoping²³⁴,Huang Juanjuan¹,Huang Siqiong¹,Li Yanfei¹,Feng Jinhui¹,Liu Jiyang¹,He Gefei¹

Affiliation:

1. The First Hospital of Changsha Changsha China

2. Department of Clinical Pharmacology Xiangya Hospital Central South University Changsha Hunan China

3. Hunan Key Laboratory of Pharmacogenetics Institute of Clinical Pharmacology Central South University Changsha Hunan China

4. National Clinical Research Center for Geriatric Disorders Xiangya Hospital Central South University Changsha Hunan China

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1866

Reference26 articles.

1. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle

2. World Health Organization.Coronavirus disease (COVID‐2019) situation reports. (2020). Accessed March 1 2020.

3. General Office of the National Health Commission of People's Republic of China Office of National Administration.Diagnosis and treatment of novel coronavirus pneumonia (revised version fifth). (2020). Accessed March 1 2020.

4. Drug treatment options for the 2019-new coronavirus (2019-nCoV)

5. Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019‐nCoV Infection

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathogenic mechanisms of cardiovascular damage in COVID-19;Molecular Medicine;2024-06-19

2. Insight into COVID-19 associated liver injury: Mechanisms, evaluation, and clinical implications;Hepatology Forum;2024

3. A narrative review on adverse drug reactions of COVID-19 treatments on the kidney;Open Medicine;2024-01-01

4. Safety profile of methotrexate used off-label in ectopic pregnancy: an active monitoring study based on a Chinese hospital pharmacovigilance system;Current Medical Research and Opinion;2023-11-24

5. Age-dependent immune responses in COVID-19-mediated liver injury: focus on cytokines;Frontiers in Endocrinology;2023-08-15